Aurora Cannabis Inc. · TSX:ACB
Aurora Cannabis — Q1 2024 Earnings Presentation
6 slides from Aurora Cannabis's earnings presentation, Aug 10, 2023
Slide 1: Fiscal Q1 2024 Supplemental Information
FISCAL Q1 2024 SUPPLEMENTAL INFORMATION AUGUST 2023
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this presentation that are not statements of historical fact may be deemed
Slide 3: Key Takeaways
Key Takeaways Opening the Diversified global footprint with a presence in 12 global cannabis markets World to Significant growth opportunities in high margin domestic and international medical cannabis segments Cannabis Achieved Strong year-over-year revenue growth across all business units in
Slide 4: FY24 Q1 Key Financial Highlights
FY24 Q1 Key Financial Highlights • Consolidated Results • Adjusted EBITDA (1) was 2.2 million in Q1, a record for the company and the third sequential quarter of positive adjusted EBITDA. During the prior year quarter, Adjusted EBITDA was -$8.8 million. The increase is primarily Medical Adult Rec Pl
Slide 5: Year-over-Year Financial Trends
Year-over-Year Financial Trends Metric FY22 Q4 (1) FY24 Q1 YoY Movement (%) Total cannabis net revenue (2) $50.1m $55.2m 10% Plant propagation net revenue (2)(3) - $19.9m - Adjusted Gross Profit Before $25.8m $32.6m 26% Fair Value Adjustments (2) Adjusted SG&A (2)(4) $34.8m $29.5m 15% Adjusted EBITD
Slide 6: Investor Presentation
INVESTOR PRESENTATION Email: aurora@icrinc.com Website: auroramj.com/investors